Agios Pharmaceuticals | AGIO - EPS Earnings Per Share


Agios Pharmaceuticals reported $-1.69 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -1.69 -1.79 -1.55 Apr/29
FY2025Q4 Dec/2025 -1.86 -1.95 -1.44 Feb/12
FY2025Q3 Sep/2025 -1.78 -1.91 16.22 Oct/30
FY2025Q2 Jun/2025 -1.93 -1.85 -1.69 Jul/31
FY2025Q1 Mar/2025 -1.55 -1.76 -1.45 May/01




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Arrowhead Research USD -0.93 1.15 Mar/2026
Astellas Pharma JPY 24.29 31.75 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Exelixis USD 0.87 0.1 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026